Paper36795255
Neoadjuvant Therapy with Immune Checkpoint Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis.
Li S and 8 others. Ann Surg Oncol, 2023. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Neoadjuvant Therapy with Immune Checkpoint Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis. Papers, record 36795255. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36795255
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Neoadjuvant Therapy with Immune Checkpoint Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Stomach Neoplasms | Major topic |
| Neoplasms, Second Primary | Major topic |
| Humans | |
| Neoadjuvant Therapy | |
| Immune Checkpoint Inhibitors | |
| B7-H1 Antigen | |
| Prospective Studies | |
| Multicenter Studies as Topic |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82173305 | National Natural Science Foundation of China | PubMed | ||
| ZR2017MH005 | Natural Science Foundation of Shandong Province | PubMed |
Source PubMed
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 2 | 28895113 | Validation of the 8th Edition of the AJCC TNM Staging System for Gastric Cancer using the National Cancer Database. | Ann Surg Oncol | 2017 | https://conductscience.org/library/papers/28895113 | PubMed |
| 3 | 32861308 | Gastric cancer. | Lancet | 2020 | https://conductscience.org/library/papers/32861308 | PubMed |
| 4 | 16822992 | Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. | N Engl J Med | 2006 | https://conductscience.org/library/papers/16822992 | PubMed |
| 5 | 21444866 | Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21444866 | PubMed |
| 6 | 30982686 | Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. | Lancet | 2019 | https://conductscience.org/library/papers/30982686 | PubMed |
| 7 | 33353828 | Prognostic value of tumor regression grade following the administration of neoadjuvant chemotherapy as treatment for gastric/gastroesophageal adenocarcinoma: A meta-analysis of 14 published studies. | Eur J Surg Oncol | 2021 | https://conductscience.org/library/papers/33353828 | PubMed |
| 8 | 22395984 | Surgical complications in gastric cancer patients preoperatively treated with chemotherapy: their risk factors and clinical relevance. | Ann Surg Oncol | 2012 | https://conductscience.org/library/papers/22395984 | PubMed |
| 9 | 29543932 | Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial. | JAMA Oncol | 2018 | https://conductscience.org/library/papers/29543932 | PubMed |
| 10 | 28993052 | Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. | Lancet | 2017 | https://conductscience.org/library/papers/28993052 | PubMed |
| 11 | 34102137 | First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. | Lancet | 2021 | https://conductscience.org/library/papers/34102137 | PubMed |
| 12 | 29658848 | Neoadjuvant PD-1 Blockade in Resectable Lung Cancer. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29658848 | PubMed |
| 13 | 30297909 | Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. | Nat Med | 2018 | https://conductscience.org/library/papers/30297909 | PubMed |
| 14 | 27663893 | Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease. | Cancer Discov | 2016 | https://conductscience.org/library/papers/27663893 | PubMed |
| 15 | 30297911 | Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma. | Nat Med | 2018 | https://conductscience.org/library/papers/30297911 | PubMed |
| 16 | 12956787 | Methodological index for non-randomized studies (minors): development and validation of a new instrument. | ANZ J Surg | 2003 | https://conductscience.org/library/papers/12956787 | PubMed |
| 17 | 3802833 | Meta-analysis in clinical trials. | Control Clin Trials | 1986 | https://conductscience.org/library/papers/3802833 | PubMed |
| 18 | 12958120 | Measuring inconsistency in meta-analyses. | BMJ | 2003 | https://conductscience.org/library/papers/12958120 | PubMed |
| 19 | 33718040 | Neoadjuvant programmed cell death protein 1 inhibitors combined with chemotherapy in resectable non-small cell lung cancer: an open-label, multicenter, single-arm study. | Transl Lung Cancer Res | 2021 | https://conductscience.org/library/papers/33718040 | PubMed |
| 20 | 29880231 | Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial. | Lancet | 2018 | https://conductscience.org/library/papers/29880231 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42857192 | Impact of immune checkpoint inhibitors as neoadjuvant/perioperative therapy for locally advanced resectable gastric/gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42857192 | PubMed |
| 42846330 | Re-evaluation of lymph node dissection and surgical strategy for locally advanced gastric cancer in the era of neoadjuvant immunotherapy: a narrative review. | Front Oncol | 2026 | https://conductscience.org/library/papers/42846330 | PubMed |
| 42459699 | Tertiary lymphoid structures as biomarkers and therapeutic targets in neoadjuvant cancer immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42459699 | PubMed |
| 42305456 | The research progress of gastric cancer vaccines: a narrative review. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42305456 | PubMed |
| 41924604 | Efficacy and safety of perioperative immune checkpoint inhibitors combined with chemotherapy versus chemotherapy alone for locally advanced gastric or gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis of randomized phase III trials. | Front Oncol | 2026 | https://conductscience.org/library/papers/41924604 | PubMed |
| 41924230 | A Real-Time Online Nomogram Integrating Systemic Inflammatory Response Index and Lactate Dehydrogenase to Predict Pathological Response in Gastric Cancer Patients Receiving Neoadjuvant Chemoimmunotherapy. | Cancer Manag Res | 2026 | https://conductscience.org/library/papers/41924230 | PubMed |
| 41876949 | Neoadjuvant Therapy for Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma: Current Status, Challenges, and Future Perspectives. | Cancer Med | 2026 | https://conductscience.org/library/papers/41876949 | PubMed |
| 41626148 | Prediction of neoadjuvant therapy efficacy in gastric cancer: the interplay between biomarkers and radiomics and its potential for clinical translation. | Front Oncol | 2025 | https://conductscience.org/library/papers/41626148 | PubMed |
| 41607794 | Survival and multi-omics analysis of immunotherapy-based conversion treatment for initially unresectable gastric cancer. | Front Immunol | 2025 | https://conductscience.org/library/papers/41607794 | PubMed |
| 41551523 | Artificial intelligence and machine learning-driven advancements in gastrointestinal cancer: Paving the way for precision medicine. | World J Gastroenterol | 2026 | https://conductscience.org/library/papers/41551523 | PubMed |
| 41317985 | Radiation Therapy for Gastric Cancer: An ASTRO Clinical Practice Guideline. | Pract Radiat Oncol | 2026 | https://conductscience.org/library/papers/41317985 | PubMed |
| 41184754 | Therapeutic efficacy of multiple neoadjuvant regimens involving targeted therapy, immunotherapy and chemotherapy in gastric cancer: a systematic review and meta-analysis. | BMC Cancer | 2025 | https://conductscience.org/library/papers/41184754 | PubMed |
| 41114345 | Pathologic complete response of advanced hepatoid adenocarcinoma of the stomach following immuno-chemotherapy and conversion surgery: a rare case report and review of the literature. | Front Oncol | 2025 | https://conductscience.org/library/papers/41114345 | PubMed |
| 40851424 | Human Epidermal Growth Factor Receptor 2 [HER-2/neu] Amplification and Microsatellite Stable Status in Gastric and Gastroesophageal Adenocarcinoma: Assessing Frequency and Prognostic Implications at the Cancer Institute of Iran. | Cancer Rep (Hoboken) | 2025 | https://conductscience.org/library/papers/40851424 | PubMed |
| 40591222 | Escalation and de-escalation in surgery for gastric cancer. | Int J Clin Oncol | 2025 | https://conductscience.org/library/papers/40591222 | PubMed |
| 40119433 | The artificial intelligence revolution in gastric cancer management: clinical applications. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/40119433 | PubMed |
| 39967656 | Neoadjuvant chemotherapy combined with antiangiogenic therapy and immune checkpoint inhibitors for the treatment of locally advanced gastric cancer: a real - world retrospective cohort study. | Front Immunol | 2025 | https://conductscience.org/library/papers/39967656 | PubMed |
| 39871229 | Impact of Helicobacter pylori infection on neoadjuvant chemotherapy in locally advanced gastric cancer: a retrospective analysis. | BMC Cancer | 2025 | https://conductscience.org/library/papers/39871229 | PubMed |
| 39675826 | Chemotherapy combined with immunotherapy in patients with gastric cancer: protocol for a systematic review. | BMJ Open | 2024 | https://conductscience.org/library/papers/39675826 | PubMed |
| 39050856 | Prognostic value of inflammatory markers NLR, PLR, and LMR in gastric cancer patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review. | Front Immunol | 2024 | https://conductscience.org/library/papers/39050856 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36795255
GET https://conductscience.org/api/papers/v1/36795255/references?page=2